Multidisciplinary Subspecialty Pathology Research Fellowship Program
Multidisciplinary Subspecialty Pathology Research Fellowship Program
批准号:
8908891
负责人:
BOGDAN A CZERNIAK
金额:
$37.98万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-23 至 2017-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dramatic expansion of biomedical data in the post-genomic era on various organisms, including humans, has disclosed the enormous complexity of biological systems and increased our knowledge of many disease processes. This is particularly evident in reference to neoplastic disorders where molecular technologies on a genome, epigenome, transcriptome and proteomic scale have disclosed unique molecular pathways and their networks that provide significant information concerning therapeutic strategies and clinical outcomes. This in turn has affected the standard of practice of many medical disciplines including pathology. The newly developed concept of personalized and targeted therapies in cancer medicine increased and changed the traditional roles of pathology as a clinical discipline. The expanding molecular testing of tumors, with complex technologic approaches, requires a redesign of the conventional microscopic pathology services. This T32 proposal is intended to provide resources to train a new generation of pathologists via laboratory-based research training that will complement the current Accreditation Council for Graduate Medical Education-accredited clinical fellowship programs of the Department of Pathology at The University of Texas MD Anderson Cancer Center. The goal of this program is to train the next generation of physician/scientist pathologists capable of combining the conventional role of diagnostic pathology with investigative molecular approaches. To accomplish this goal, a focused 2-year research program will pair trainees with experienced educators who are also accomplished translational researchers. The trainees will work in their mentors' laboratories training in laboratory methods, processes, and team orientation needed in today's translational research. The graduates of this program will complete research projects aimed at improving patient care with patient-directed personalized treatment, concluding with the submission of a manuscript to a peer-reviewed journal. Coursework and a wide range of educational opportunities at The University of Texas MD Anderson Cancer Center will complement the laboratory research training. Combined with subspecialty clinical training, this program will produce extremely well-qualified academic, research-oriented pathologists who can, by themselves, be independent researchers and future academic mentors.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jocn.2014.09.006
发表时间:
2015-03
期刊:
JOURNAL OF CLINICAL NEUROSCIENCE
影响因子:
2
作者:
[Pachella, Laura A., Kamiya-Matsuoka, Carlos, Lee, Eva Lu T., Olar, Adriana, Yung, W. K. Alfred]
通讯作者:
Yung, W. K. Alfred
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
IDH突变体弥漫性和变性星形胶质细胞瘤在表现时的年龄相似,而生存的差异很小:谁是谁的评分问题。
DOI:
10.1007/s00401-015-1438-8
发表时间:
2015-06
期刊:
Acta neuropathologica
影响因子:
12.7
作者:
[Reuss DE, Mamatjan Y, Schrimpf D, Capper D, Hovestadt V, Kratz A, Sahm F, Koelsche C, Korshunov A, Olar A, Hartmann C, Reijneveld JC, Wesseling P, Unterberg A, Platten M, Wick W, Herold-Mende C, Aldape K, von Deimling A]
通讯作者:
von Deimling A
Squamous cell carcinoma of parotid gland associated with concurrent lymphoepithelial cysts and lymphoepithelial lesion: case report and proposed histogenesis.
腮腺鳞状细胞癌伴有淋巴上皮囊肿和淋巴上皮病变:病例报告和拟议的组织发生。
DOI:
10.1007/s12105-014-0571-3
发表时间:
2015
期刊:
Head and neck pathology
影响因子:
2.1
作者:
[Zhou,JaneH, ChristopherHolsinger,F]
通讯作者:
ChristopherHolsinger,F
DOI:
10.3109/01913123.2014.950778
发表时间:
2015-02
期刊:
Ultrastructural pathology
影响因子:
1
作者:
[Cykowski MD, Hicks J, Sandberg DI, Olar A, Bridge JA, Greipp PT, Navarro P, Kolodziej S, Bhattacharjee MB]
通讯作者:
Bhattacharjee MB
DOI:
10.1016/j.humpath.2015.12.017
发表时间:
2016-05
期刊:
Human pathology
影响因子:
3.3
作者:
[Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu J]
通讯作者:
Liu J
共 17 条
Tissue and Pathology Resources
-
批准号:8395574
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2012
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Multidisciplinary Subspecialty Pathology Research Fellowship Program
-
批准号:8337748
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2011
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Multidisciplinary Subspecialty Pathology Research Fellowship Program
-
批准号:8214237
-
项目类别:
-
资助金额:$21.38万
-
财政年份:2011
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Improving Diagnosis of Bladder Cancer
-
批准号:8230252
-
项目类别:
-
资助金额:$20.32万
-
财政年份:2011
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Multidisciplinary Subspecialty Pathology Research Fellowship Program
-
批准号:8540854
-
项目类别:
-
资助金额:$37.33万
-
财政年份:2011
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Pathology and Data Management
-
批准号:8230260
-
项目类别:
-
资助金额:$20.32万
-
财政年份:2011
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Multidisciplinary Subspecialty Pathology Research Fellowship Program
-
批准号:8721730
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2011
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer
-
批准号:8287655
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2010
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer
-
批准号:8468663
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2010
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer
-
批准号:8105195
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2010
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Specimen Core
-
批准号:7729511
-
项目类别:
-
资助金额:$12.49万
-
财政年份:2008
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
Forerunner Genes: A Novel Class of Early Detection Markers for Bladder Cancer
-
批准号:7729503
-
项目类别:
-
资助金额:$24.51万
-
财政年份:2008
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:6074937
-
项目类别:
-
资助金额:$65.11万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:6522563
-
项目类别:
-
资助金额:$77.4万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:7113134
-
项目类别:
-
资助金额:$51.5万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:7483250
-
项目类别:
-
资助金额:$52.76万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:6175327
-
项目类别:
-
资助金额:$73.49万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:6644812
-
项目类别:
-
资助金额:$77.41万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:6848379
-
项目类别:
-
资助金额:$47.16万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
EARLY DETECTION OF URINARY BLADDER CANCER
-
批准号:6377572
-
项目类别:
-
资助金额:$84.67万
-
财政年份:1999
-
负责人:BOGDAN A CZERNIAK
-
依托单位:
海外基金